Adrenergic effects on the biology of the adult mammalian cardiocyte

Circulation

Volumn 85, Issue 2, 1992, Pages 790-804

  Mann, Douglas L ^a   Kent, Robert L ^c   Parsons, Bruce ^c   Cooper IV, George ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c NONE

Author keywords

Cardiocyte; Catecholamine; Norepinephrine; adrenoceptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; BUCLADESINE; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; LIDOCAINE; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; PROPRANOLOL; TETRODOTOXIN; VERAPAMIL;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CAT; CELL CULTURE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CALCIUM; CATECHOLAMINES; CELL AGING; CELL SURVIVAL; CYCLIC AMP; HEART; MYOCARDIUM; NOREPINEPHRINE; PHENYLALANINE; RNA; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHOMIMETICS;

EID: 0026558346     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.2.790     Document Type: Article

References (71)

1. Cannon WB: Methods of demonstrating adrenal secretion and its nervous control, in Cannon WB (ed): Bodily Changes In Pain, Hunger, Fear and Rage. New York, D Appleton and Co, 1923, pp 40-51
2. Szakacs JE, Dimmette RM, Coward EC: Pathologic implications of the catecholamines, epinephrine, and norepinephrine. US Armed Forces Med J 1959;10:908-925
3. Goldstein S, Killip T: Catecholamine depletion in thyrotoxicosis: Effect of guanethidine on cardiovascular dynamics. Circulation 1965;31:219-227
4. Raab W: The sympathogenic biochemical trigger mechanism of angina pectoris. Am J Cardiol 1962;9:576-584
5. Raab W, Van Lith P, Lopeschkin B, Herrlich HC: Catecholamine-induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work. Am J Cardiol 1962;9:455-470
6. Cohn JN, Levine TB, Olivare MT: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823
7. Rona G, Chappel CI, Balazs T, Gaudry R: An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 1959;67:443-455
8. Reichenbach DD, Benditt EP: Catecholamines and cardiomyopathy: The pathogenesis and potential importance of myofibriallar degeneration. Hum Pathol 1970;1:125-150
9. Ferrans VJ, Hibbs RG, Black WC, Weilbaecher DG: Isoproterenol-induced myocardial necrosis: A histochemical and electron microscopic study. Am Heart J 1964;68:71-90
10. Somani P, Laddu AR, Hardman HF: Nutritional circulation in the heart: III. Effects of isoproterenol and beta adrenergic blockage on myocardial hemodynamics and rubidium-86 extraction in the isolated supported heart preparation. J Pharmacol Exp Ther 1970;175:577-592
11. Boutet M, Huttner I, Rona G: Aspect microcirculatoire des lesions myocardiques provoquees par l'infusion de catecholamines: Etude ultrastructurale a l'aide de traceurs de diffusion: 1. Isoproterenol. Path Biol 1973;21:811-825
12. Boutet M, Huttner I, Rona G: Aspect microcirculatoire des lesions myocardiques provoquees par l'infusion de catecholamines: Etude ultrastructurale a l'aide de traceurs de diffusion: Norepinephrine. Path Biol 1974;22:377-387
13. Rona G, Bouter M, Huttner I: Membrane permeability alterations as manifestation of early cardiac muscle cell injury, in Fleckenstein A, Rona G (eds): Recent Advances in Studies on Cardiac Structure and Metabolism, Pathophysiology and Morphology of Myocardial Cell Alterations. Baltimore, Md, University Park Press, 1975, vol 6, pp 439-451
14. Rona G, Huttner I, Boutet M: Microcirculatory changes in myocardium with particular reference to catecholamine-induced cardiac muscle cell injury, in Meesen H (ed): Handbuch der allgemeinen Pathologie III/7: Mikrozirkulation/Microcirculation. Heidelberg/New York, Springer, 1977, pp 791-888
15. Fleckenstein A: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions, in Harris P, Opie LH (eds): Calcium and the Heart. London, Academic Press, 1971, pp 135-188
16. Lehr D: Tissue electrolyte alterations in disseminated myocardial necrosis. Ann NY Acad Sci 1969;156:344-378
17. Bloom S, Davis DL: Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol 1972;69:459-470
18. Bhagat B, Sullivan JM, Fischer VW, Nadel EM, Dhalla NS: cAMP activity and isoproterenol-induced myocardial injury in rats, in Kobayashi Y, Ito Y, Rona G (eds): Recent Advances in Studies on Cardiac Structure and Metabolism. Baltimore, Md, University Park Press, 1978, pp 465-470
19. Opie LH, Walpoth B, Barsacchi R: Calcium and catecholamines: Relevance to cardiomyopathies and significance in therapeutic strategies. J Mol Cell Cardiol 1985;17(suppl 2):21-34
20. Wheatley AM, Thandroyen FT, Opie LH: Catecholamine-induced myocardial cell damage: Catecholamines or adrenochrome. J Mol Cell Cardiol 1985;17:349-359
21. Downing SE, Lee JC: Contribution of α-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy. Circ Res 1983;52:471-478
22. Downing SE, Chen V: Myocardial injury following endogenous catecholamine release in rabbits. J Mol Cell Cardiol 1985;17:377-387
23. Persoon-Rothert M, van der Valk-Kokshoorn EJM, Egas-Kenniphaas JM, Mauve I, van der Laarse A: Isoproterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. J Mol Cell Cardiol 1989; 21:1285-1291
24. Horak AR, Podzuweit T, Opie LH: Cyclic AMP as mediator of catecholamine-induced enzyme release from isolated perfused working rat heart, in Tajuddin M, Das PK, Tariq M, Dhalla NS (eds): Advances in Myocardiology. Baltimore, Md, University Park Press, 1980, vol 1, pp 367-373
25. Dhalla NS, Yates JC, Lee SL, Singh A: Functional and subcellular changes in the isolated rat heart perfused with oxidized isoproterenol. J Mol Cell Cardiol 1978;10:31-41
26. Ferrans VJ, Hibbs RG, Black WC, Weilbaecher DG: Isoproterenol-induced myocardial necrosis: A histochemical and electron microscopic study. Am Heart J 1964;68:71-96
27. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS: Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982;60:1390-1397
28. Singal PK, Beamish RE, Dhalla NS: Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983;161:391-401
29. Rona G: Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306
30. Mann DL, Kent RL, Cooper G IV: Load regulation of the properties of adult feline cardiocytes: Growth induction by cellular deformation. Circ Res 1989;64:1079-1090
31. Jacobson SL, Piper HM: Cell cultures of adult cardiomyocytes as models of the myocardium. J Mol Cell Cardiol 1986;18: 661-678
32. Bevan JA: Norepinephrine and the presynaptic control of adrenergic transmitter release. Fed Proc 1978;39:187-190
33. Waldenstrom AP, Hjalmarson AC, Thornell L: A possible role of noradrenaline in the development of myocardial infarction. Am Heart J 1978;95:43-51
34. Dietz R, Schomig A, Strasser R, Kubler W: Catecholamines in myocardial hypoxia and ischemia, in Delius W, Gerlach E, Grobecker H, Kubler W (eds): Catecholamines and the Heart. Berlin/Heidelberg/New York, Springer-Verlag, 1981, pp 201-209
35. Schumann HJ, Endoh M, Wagner J: Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by α- and β-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1974;284:133-148
36. Kimura S, Cameron JS, Kozlovskis PL, Basset AL, Myerburg RJ: Delayed afterdepolarizations and triggered activity induced in feline Purkinje fibers by α-adrenergic stimulation in the presence of elevated calcium levels. Circulation 1984;70: 1074-1082
37. Szasz G, Gruber W, Bernt E: Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 1976;22:650-656
38. Claycomb WC, Palazzo MC: Culture of the terminally differentiated adult cardiac muscle cell: A light and scanning electron microscope study. Dev Biol 1980;80:466-482
39. 2+ tolerance, electrophysiology, and ultrastructure. Am J Physiol 1983;245: H830-H839
40. Cooper G IV, Mercer WE, Hoober JK, Gordon PR, Kent RL, Lauva IK, Marino TA: Load regulation of the properties of adult feline cardiocytes. Circ Res 1986;58:692-705
41. Florio VA, Ross EM: Regulation of the catalytic component of adenylate cyclase: Potentiative interaction of stimulatory ligands and 2′,5′-dideoxyadenosine. Mol Pharmacol 1983;24: 195-202
42. Newman WH, Becker BF, Heier M, Nees S, Gerlach E: Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: Studies in isolated guinea pig hearts. Pflugers Arch 1988;413:1-7
43. Seamon KB, Daly JW: Forskolin: Its biological and chemical properties, in Greengard P, Robison GA (eds): Advances in Cyclic Nucleotide and Protein Phosphorylation Research. New York, Raven Press, 1986, p 3
44. Cooper G IV, Kent RL, Uboh CE, Thompson EW, Marino TA: Hemodynamic versus adrenergic control of cat right ventricular hypertrophy. J Clin Invest 1985;75:1403-1414
45. Smith PK, Krohn RI, Hermansen GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olsen BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Chem 1985;150:76-85
46. 2+ current. Nature 1982;298: 576-578
47. Rinaldi ML, Capony JP, Demaille JG: The cyclic AMP-dependent modulation of cardiac sarcolemmal slow calcium channels. J Mol Cell Cardiol 1982;14:279-289
48. Tsien RW, Hess P, McCleskey EW, Rosenberg RL: Calcium channels: Mechanisms of selectivity, permeation, and block. Ann Rev Biophys Chem 1987;16:265-290
49. Carafoli E: How calcium crosses plasma membranes including the sarcolemma, in Opie LH (ed): Calcium Antagonists and Cardiovascular Disease. New York, Raven Press, 1984, pp 29-41
50. Dudel J, Peper K, Rudel R, Trautwein W: The effect of tetrodotoxin on the membrane current in cardiac muscle (Purkinje fibers). Pflugers Arch 1967;295:213-226
51. Hess P, Lansman JB, Tsien RW: A novel type of cardiac calcium channel in ventricular cells. Nature 1985;316:443-446
52. Arnsdorf MF, Bigger JT: Effect of lidocaine hydrochloride on membrane conductance in mammalian Purkinje fibers. J Clin Invest 1972;51:2252-2263
53. 2+-force relationship studied with fura-2 during stimulation of rat aortic smooth muscle. Am J Physiol 1988;254:H840-H854
54. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450
55. Kao JPY, Harootunian AT, Tsien RY: Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 1989;264:8179-8184
56. Lundin A, Hasenson M, Persson J, Pousette A: Estimation of biomass in growing cell lines by adenosine triphosphate assay. Meth Enzymol 1986;133:27-42
57. Lundin A: Measurement of ATP, in Kricka LJ, Carter TJN (eds): Clinical and Biochemical Luminescence. New York, Dekker, 1982, p 43
58. Smith PK, Krohn RI, Hermansen GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olsen J, Klenk DC: Measurement of protein using bicinchonic acid. Anal Chem 1985;150:76-85
59. Winer BJ: Decision and analysis of single factor experiments, in Winer BJ (ed): Statistical Principles in Experimental Design. New York, McGraw-Hill Book Co, 1962, pp 201-205
60. Katz AM, Pappano AJ, Messineo FC, Smilowitz H, Nash-Adler P: Calcium-channel-blocking drugs, in Fozzard HA, Jennings RB, Haber E, Katz AM, Morgan HE (eds): The Heart and Cardiovascular System. New York, Raven Press, 1986, pp 1597-1609
61. Fabiato A, Fabiato F: Excitation-contraction coupling of isolated cardiac fibers with disrupted or closed sarcolemmas: Calcium-dependent cyclic and tonic contractions. Circ Res 1972;31:293-307
62. Corr PB, Shayman JA, Kramer JB, Kipnis RJ: Increased α-adrenergic receptors in ischemic cat myocardium. J Clin Invest 1981;67:1232-1236
63. Mukherjee AZ, Haghani Z, Brady J, Bush L, McBride W, Buja LM, Willerson JT: Differences in myocardial α- and β-adrenergic receptor numbers in different species. Am J Physiol 1983;245:H957-H961
64. Bristow MR, Minobe W, Rasmussen R, Hershberger RE, Hoffman BB: Alpha-1 adrenergic receptors in the non-failing and failing human heart. J Pharmacol Exp Ther 1988;247: 1039-1045
65. Baroldi G: Human myocardial infarction: Coronarogenic and noncoronarogenic coagulation necrosis, in Bajusz E, Rona G (eds): Recent Advances in Studies on Cardiac Structure and Metabolism: Myocardiology. Baltimore, Md, University Park Press, 1972, vol 1, pp 399-41 3
66. D'Agostino AN: An electron microscopic study of cardiac necrosis produced by 9 α-fluorocortisol and sodium phosphate. Am J Pathol 1964;45:633-644
67. Bloom S, Sweat FW: Covariance of myocardial cyclic AMP and calcium during β-adrenergic stimulation in vivo. Res Comm Chem Path Pharm 1974;8:505-514
68. Josue O: Hypertrophie cardiaque causee par l'adrenaline et la toxine typhique. C R Soc Biol (Paris) 1907;63:285-286
69. Swedberg K, Waagstein F, Hjalmarson A, Wallentin I: Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979;1:1374
70. Engelmeier RS, O'Connel JB, Walsh R, Rad N, Scanion PJ, Gunnar RM: Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial. Circulation 1985;72:536-546
71. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Kjalmarson A: Long-term β-blockade in dilated cardiomyopathy. Circulation 1989;80:551-563